Contact this trialFirst, we need to learn more about you.
Alkylating Agent
Cyclophosphamide +6 More for Intraocular Lymphoma
Recruiting2 awardsPhase 1 & 2
Chicago, Illinois
This trial is testing the side effects and best dose of lenalidomide when given with chemotherapy to treat patients with MYC-associated B-cell lymphomas. Lenalidomide works by blocking growth of new blood vessels and enzymes needed for cell growth. Chemo drugs work in different ways to stop cancer cell growth. Monoclonal antibodies may also block cancer growth.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service